Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study

Jiri Kolar, Andrea Feu Llaurado, Monika Ulamec, Faruk Skenderi, Delia Perez-Montiel, Isabel Alvarado-Cabrero, Stela Bulimbasic, Maris Sperga, Maria Tretiakova, Adeboye O. Osunkoya, Joanna Rogala, Eva Comperat, Viliam Gal, Ana Dunatov, Kristyna Pivovarcikova, Kvetoslava Michalova, Adriena Bartos Vesela, Maryna Slisarenko, Andrea Peterikova Strakova, Tomas Pitra, Milan Hora, Michal Michal, Reza Alaghehbandan, Ondrej Hes

Open source

DOI
10.1016/j.anndiagpath.2022.151978
Published
2022-10
Container
Annals of Diagnostic Pathology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.anndiagpath.2022.151978,
  title = {Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study},
  author = {Jiri Kolar and Andrea Feu Llaurado and Monika Ulamec and Faruk Skenderi and Delia Perez-Montiel and Isabel Alvarado-Cabrero and Stela Bulimbasic and Maris Sperga and Maria Tretiakova and Adeboye O. Osunkoya and Joanna Rogala and Eva Comperat and Viliam Gal and Ana Dunatov and Kristyna Pivovarcikova and Kvetoslava Michalova and Adriena Bartos Vesela and Maryna Slisarenko and Andrea Peterikova Strakova and Tomas Pitra and Milan Hora and Michal Michal and Reza Alaghehbandan and Ondrej Hes},
  year = {2022},
  journal = {Annals of Diagnostic Pathology},
  doi = {10.1016/j.anndiagpath.2022.151978},
  url = {https://doi.org/10.1016/j.anndiagpath.2022.151978}
}

RIS

TY  - JOUR
TI  - Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study
AU  - Jiri Kolar
AU  - Andrea Feu Llaurado
AU  - Monika Ulamec
AU  - Faruk Skenderi
AU  - Delia Perez-Montiel
AU  - Isabel Alvarado-Cabrero
AU  - Stela Bulimbasic
AU  - Maris Sperga
AU  - Maria Tretiakova
AU  - Adeboye O. Osunkoya
AU  - Joanna Rogala
AU  - Eva Comperat
AU  - Viliam Gal
AU  - Ana Dunatov
AU  - Kristyna Pivovarcikova
AU  - Kvetoslava Michalova
AU  - Adriena Bartos Vesela
AU  - Maryna Slisarenko
AU  - Andrea Peterikova Strakova
AU  - Tomas Pitra
AU  - Milan Hora
AU  - Michal Michal
AU  - Reza Alaghehbandan
AU  - Ondrej Hes
PY  - 2022
JO  - Annals of Diagnostic Pathology
DO  - 10.1016/j.anndiagpath.2022.151978
UR  - https://doi.org/10.1016/j.anndiagpath.2022.151978
ER  - 

APA

Kolar, J., Llaurado, A. F., Ulamec, M., Skenderi, F., Perez-Montiel, D., Alvarado-Cabrero, I., Bulimbasic, S., Sperga, M., Tretiakova, M., Osunkoya, A. O., Rogala, J., Comperat, E., Gal, V., Dunatov, A., Pivovarcikova, K., Michalova, K., Vesela, A. B., Slisarenko, M., Strakova, A. P., Pitra, T., Hora, M., Michal, M., Alaghehbandan, R., & Hes, O. (2022). Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study. Annals of Diagnostic Pathology. https://doi.org/10.1016/j.anndiagpath.2022.151978

Source records